tetrabenazine has been researched along with Congenital Hypothyroidism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billette de Villemeur, T; Camuzat, A; Caubel, I; Chantot-Bastaraud, S; Charles, P; Devos, D; Doummar, D; Durr, A; Epaud, R; Goizet, C; Gras, D; Guillot, L; Héron, B; Jonard, L; Kemlin, I; Koht, J; Lion-François, L; Louha, M; Motte, J; Moutard, ML; Polak, M; Rodriguez, D; Roze, E; Sanlaville, D; Tallot, M; Vidailhet, M; Vuillaume, I | 1 |
1 other study(ies) available for tetrabenazine and Congenital Hypothyroidism
| Article | Year |
|---|---|
Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene.
Topics: Adrenergic Uptake Inhibitors; Adult; Age of Onset; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Chorea; Chromosome Disorders; Cognition Disorders; Congenital Hypothyroidism; DNA Mutational Analysis; Female; Follow-Up Studies; France; Genes, Dominant; Humans; Infant; Male; Mutation; Neuropsychological Tests; Nuclear Proteins; Phenotype; Prognosis; Protein Array Analysis; Respiratory Tract Diseases; Tetrabenazine; Thyroid Nuclear Factor 1; Transcription Factors; Treatment Outcome | 2012 |